D-132-2013 Class II Terminated

Recalled by West-Ward Pharmaceutical Corp. — Eatontown, NJ

FDA drug recall D-132-2013 was initiated by West-Ward Pharmaceutical Corp. on Nov 30, 2012 and is designated Class II. Reason for recall: Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets. The recall status is terminated (terminated Jul 9, 2014). Affected quantity: 43,478 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 30, 2013
Initiation Date
Nov 30, 2012
Termination Date
Jul 9, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
43,478 bottles

Product description

Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1264-01) and b) 1000-count tablets per bottle (NDC 0143-1264-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.

Reason for recall

Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets.

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot #: 69392A, 69393A, 69394A, 69395A, 69396A, 69397A , Exp 09/15; 69495A, 69496A, 69497A, 69498A, 69524A, 69525A, Exp 10/15

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-132-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-132-2013. Report a data issue: hello@regdatalab.com.